← Open Payments lookup

CAROLINE INGE: Open Payments

NPI 1538791074 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$671 in 28 payments from 13 companies in 2025. Trend: 2023 $14 · 2024 $190 · 2025 $671

Food & beverage: $671
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$129
Merck Sharp & Dohme LLC5$120
Incyte Corporation4$103
Takeda Pharmaceuticals U.S.A., Inc.3$67
Janssen Biotech, Inc.3$61
JAZZ PHARMACEUTICALS INC.1$35
Exelixis Inc.1$30
Monteris Medical Corporation1$24
Aveo Pharmaceuticals, Inc.1$23
TerSera Therapeutics LLC1$22

Products named: IMFINZI, KEYTRUDA, FRUZAQLA, MONJUVI, RYBREVANT, CABOMETYX, JAKAFI, PEMAZYRE.

Industry payments across AL — which companies pay providers there.